Grupo DGA Bionanosurf

Research group at the Aragon Nanoscience and Materials Institute (INMA)

Bionanosurf is a research group at INMA (CSIC–Unizar) dedicated to the design, functionalisation, characterisation and preclinical validation of nanotechnologies aimed at improving diagnosis and treatment of diseases. Our work spans from molecular design and materials engineering to translational pipelines with clinical and industrial collaborators.

Principal investigator labs
9
Researchers & trainees
60+
Active projects
40+
Publications since 2015
350+
Bionanosurf hero illustration Bionanosurf hero illustration (dark)
Bionanosurf research group

Research Highlights

Translating nanotechnology from concept to clinic

The group’s activity is organised into four axes that reflect a complete research pathway—from synthesis and biofunctionalisation to validation and transfer.

Axis A

Nanoconjugates & therapeutic delivery

Multifunctional nanoconjugates based on natural and synthetic polymers engineered to transport antibiotics, siRNA, antimicrobial peptides or inorganic nanoparticles. These systems target infections such as tuberculosis, as well as pancreatic and colon cancer and specific rare diseases.

Learn about controlled delivery

Axis B

Magnetic nanoactuators

Magnetic nanoparticles capable of generating heat under external fields to modulate enzymes, receptors and cellular pathways. These systems support controlled release, mechanobiological studies and remote actuation strategies relevant to oncology and biosensing.

View magnetic actuator studies

Axis C

Nanobiosensors

Lateral-flow and calorimetric biosensing platforms that use plasmonic nanoparticles to achieve femtomolar sensitivity. Applications include liquid biopsy approaches for early pancreatic cancer detection and point-of-care diagnostics for respiratory viruses such as SARS-CoV-2, influenza and RSV.

Dive into biosensing

Axis D

Quality & technology transfer

Protocols aligned with GLP/GMP principles and shared processes that connect INMA infrastructures, materials characterisation, biological testing and regulatory knowledge. These frameworks support the safe, efficient and reproducible transfer of nanoformulations and medical nanodevices.

See translational standards

Capabilities

Instrumentation and expertise the consortium brings to every project

Bionanosurf integrates nanomaterial synthesis, surface chemistry, magnetic and optical characterisation, biological testing and translational workflows. This combination enables iterative development between design, experimental validation and preclinical assessment across the four axes.

  • Advanced characterisation

    Magnetic, optical and structural methods to connect nanoparticle properties with biological performance.

  • Biological validation

    In vitro and in vivo studies assessing biodistribution, hyperthermia efficacy and extracellular matrix responses.

  • Data and quality workflows

    Documentation and practices aligned with GLP/GMP that support translational collaborations.

Magnetic nanoparticle workflows

• Sample synthesis suites for polymers, ferrites, and hybrid nanoparticles.

• Instrument racks for magnetometry, calorimetry, and optical sensing.

• Collaboration spaces for bio, chem, physics, and data teams.

Contact

Tell us about your collaboration idea

Whether you are preparing a research proposal, developing a diagnostic method or exploring partnerships in nanomedicine and biosensing, the group coordinates collaboratively across laboratories.

Contact coordination team
Email
contact@bionanosurf.unizar.es
Phone
+34 976 76 28 61
Address
INMA, C/ Pedro Cerbuna 12, 50009 Zaragoza, Spain